India and US Coordinate Crackdown on Synthetic Drug Cartels

India and the United States convened the second India–US Drug Policy Executive Working Group meeting in New Delhi on November 2–3, 2026. The delegations focused on dismantling the illicit ecosystems of transnational drug cartels by targeting financiers, chemical suppliers, and logistical facilitators rather than street-level operatives.

Sara Carter, Director of the Office of National Drug Control Policy, emphasized that bilateral cooperation is vital to disrupting trafficking networks and preventing the diversion of chemical precursors into global markets. The discussions highlighted India's Vision Roadmap 2026–2029, a network-centric enforcement strategy aiming for a drug-free India by 2029.

Officials reviewed the results of Operation MedMax, a joint effort with the U.S. Drug Enforcement Administration that exposed an international pharmaceutical trafficking syndicate, and Operation WIPE, which targets illegal online listings of controlled substances such as fentanyl. U.S. Ambassador to India Sergio Gor stated that the partnership is delivering operational results by choking off precursor chemicals and dismantling cartels.

Both nations reaffirmed their commitment to regular intelligence exchanges and the safeguarding of pharmaceutical supply chains to counter adaptive narcotics networks. This meeting follows the inaugural session held in Washington, D.C., in January 2026.